Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Neoplasms 7Depression 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Anxiety Disorders 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Prostatic Hyperplasia 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Fatigue 2

Interventions

Vitamin D 1Therapeutics 1Proton Pump Inhibitors 1Probiotics 1Observation 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Helicobacter Infections × Therapeutics × 1 year × Clear all
NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡